In response, Arena submitted more material to the agency, including a trial of the drug in 604 patients with type 2 diabetes. After a year in the study, diabetes patients given lorcaserin lost 3.1% more weight than those on a placebo,
See more here
Related posts:
- Amylin Gains After Diabetes Drug Wins Approval For Expanded Use It has been approved for patients taking other diabetes medicines...
- Lorcaserin Phase 3 Trial Data On Type 2 Diabetes To Be Presented Amylin gets European approval for weekly diabetes drug Bydureon, which...
- Diabetes Drug Dapagliflozin Rejected By FDA Panel Also, since so many calories are excreted through the urine,...
- Experimental Obesity Drug Beats Placebo Again But studies show that shedding even that amount can have...
- Wyoming Inmate Fitness Program Wins National Award One success story was an inmate with diabetes who learned...